Clinical Trial Update: Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating the safety and efficacy of a grass pollen allergen vaccine. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Grass pollen allergen vaccine

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED